CEVA INC (CEVA) Stock Fundamental Analysis
NASDAQ:CEVA - Nasdaq - US1572101053 - Common Stock - Currency: USD
CEVA gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. While CEVA has a great health rating, there are worries on its profitability. CEVA shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
In the past year CEVA was profitable.
CEVA had a positive operating cash flow in the past year.
CEVA had negative earnings in 4 of the past 5 years.
Of the past 5 years CEVA 4 years had a positive operating cash flow.
1.2 Ratios
CEVA has a Return On Assets of -2.15%. This is in the lower half of the industry: CEVA underperforms 63.64% of its industry peers.
The Return On Equity of CEVA (-2.48%) is worse than 61.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.15% | ||
| ROE | -2.48% | ||
| ROIC | N/A |
ROA(3y)-4.76%
ROA(5y)-2.99%
ROE(3y)-5.58%
ROE(5y)-3.51%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Gross Margin value of 87.40%, CEVA belongs to the best of the industry, outperforming 99.09% of the companies in the same industry.
In the last couple of years the Gross Margin of CEVA has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for CEVA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 87.4% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.67%
GM growth 5Y-0.05%
2. Health
2.1 Basic Checks
CEVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CEVA has been increased compared to 1 year ago.
The number of shares outstanding for CEVA has been increased compared to 5 years ago.
CEVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 8.57 indicates that CEVA is not in any danger for bankruptcy at the moment.
CEVA has a Altman-Z score of 8.57. This is in the better half of the industry: CEVA outperforms 73.64% of its industry peers.
CEVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 8.57 |
ROIC/WACCN/A
WACC11.26%
2.3 Liquidity
CEVA has a Current Ratio of 7.45. This indicates that CEVA is financially healthy and has no problem in meeting its short term obligations.
CEVA has a Current ratio of 7.45. This is amongst the best in the industry. CEVA outperforms 89.09% of its industry peers.
A Quick Ratio of 7.45 indicates that CEVA has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 7.45, CEVA belongs to the top of the industry, outperforming 92.73% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.45 | ||
| Quick Ratio | 7.45 |
3. Growth
3.1 Past
CEVA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 860.00%, which is quite impressive.
CEVA shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.60% yearly.
Looking at the last year, CEVA shows a very strong growth in Revenue. The Revenue has grown by 20.23%.
Measured over the past years, CEVA shows a small growth in Revenue. The Revenue has been growing by 4.17% on average per year.
EPS 1Y (TTM)860%
EPS 3Y-17.12%
EPS 5Y-8.6%
EPS Q2Q%220%
Revenue 1Y (TTM)20.23%
Revenue growth 3Y-4.48%
Revenue growth 5Y4.17%
Sales Q2Q%9.85%
3.2 Future
The Earnings Per Share is expected to grow by 38.80% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 9.59% on average over the next years. This is quite good.
EPS Next Y28.46%
EPS Next 2Y47.11%
EPS Next 3Y38.8%
EPS Next 5YN/A
Revenue Next Year4.1%
Revenue Next 2Y10.12%
Revenue Next 3Y9.59%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 44.50, the valuation of CEVA can be described as expensive.
CEVA's Price/Earnings is on the same level as the industry average.
CEVA is valuated expensively when we compare the Price/Earnings ratio to 26.55, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 26.68, the valuation of CEVA can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CEVA is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 22.40. CEVA is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.5 | ||
| Fwd PE | 26.68 |
4.2 Price Multiples
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CEVA is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 484.29 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CEVA's earnings are expected to grow with 38.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.56
PEG (5Y)N/A
EPS Next 2Y47.11%
EPS Next 3Y38.8%
5. Dividend
5.1 Amount
No dividends for CEVA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:CEVA (6/12/2025, 3:05:53 PM)
21.36
-0.08 (-0.37%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners89.78%
Inst Owner Change3.98%
Ins Owners2.67%
Ins Owner Change26.46%
Market Cap510.93M
Analysts81.67
Price Target34.68 (62.36%)
Short Float %5.65%
Short Ratio4.5
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.06%
Min EPS beat(2)-15.97%
Max EPS beat(2)-0.15%
EPS beat(4)2
Avg EPS beat(4)159.87%
Min EPS beat(4)-15.97%
Max EPS beat(4)614.39%
EPS beat(8)3
Avg EPS beat(8)31.07%
EPS beat(12)5
Avg EPS beat(12)15.42%
EPS beat(16)9
Avg EPS beat(16)19%
Revenue beat(2)1
Avg Revenue beat(2)-2.93%
Min Revenue beat(2)-9.83%
Max Revenue beat(2)3.96%
Revenue beat(4)2
Avg Revenue beat(4)1.84%
Min Revenue beat(4)-9.83%
Max Revenue beat(4)13.87%
Revenue beat(8)2
Avg Revenue beat(8)-4.06%
Revenue beat(12)3
Avg Revenue beat(12)-7.15%
Revenue beat(16)7
Avg Revenue beat(16)-3.79%
PT rev (1m)-8.52%
PT rev (3m)-8.52%
EPS NQ rev (1m)-48%
EPS NQ rev (3m)-48%
EPS NY rev (1m)-11.41%
EPS NY rev (3m)-11.41%
Revenue NQ rev (1m)-7.92%
Revenue NQ rev (3m)-7.92%
Revenue NY rev (1m)-1.3%
Revenue NY rev (3m)-5.38%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.5 | ||
| Fwd PE | 26.68 | ||
| P/S | 4.68 | ||
| P/FCF | 484.29 | ||
| P/OCF | 149.53 | ||
| P/B | 1.9 | ||
| P/tB | 2.44 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.48
EY2.25%
EPS(NY)0.8
Fwd EY3.75%
FCF(TTM)0.04
FCFY0.21%
OCF(TTM)0.14
OCFY0.67%
SpS4.56
BVpS11.25
TBVpS8.74
PEG (NY)1.56
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.15% | ||
| ROE | -2.48% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 87.4% | ||
| FCFM | 0.97% |
ROA(3y)-4.76%
ROA(5y)-2.99%
ROE(3y)-5.58%
ROE(5y)-3.51%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.67%
GM growth 5Y-0.05%
F-Score6
Asset Turnover0.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 58.8% | ||
| Cap/Sales | 2.16% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 7.45 | ||
| Quick Ratio | 7.45 | ||
| Altman-Z | 8.57 |
F-Score6
WACC11.26%
ROIC/WACCN/A
Cap/Depr(3y)65%
Cap/Depr(5y)55.38%
Cap/Sales(3y)3.01%
Cap/Sales(5y)2.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)860%
EPS 3Y-17.12%
EPS 5Y-8.6%
EPS Q2Q%220%
EPS Next Y28.46%
EPS Next 2Y47.11%
EPS Next 3Y38.8%
EPS Next 5YN/A
Revenue 1Y (TTM)20.23%
Revenue growth 3Y-4.48%
Revenue growth 5Y4.17%
Sales Q2Q%9.85%
Revenue Next Year4.1%
Revenue Next 2Y10.12%
Revenue Next 3Y9.59%
Revenue Next 5YN/A
EBIT growth 1Y48.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year252.3%
EBIT Next 3Y100.68%
EBIT Next 5YN/A
FCF growth 1Y109.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y142.82%
OCF growth 3Y-48.76%
OCF growth 5Y-18.53%